European Federation of Pharmaceutical Industries and Associations

In vitro diagnostics

New EU in vitro regulations delaying clinical trials

21 March 2023

New EU legislation designed to improve public health is delaying clinical trials and blocking access to new treatments for cancer and rare diseases, says the European Federation of Pharmaceutical Industries and Associations (EFPIA). The number of clinical trials delayed is expected to run into the hundreds, affecting up to 42,200 patients over the next three […]

EU flag

Can Europe become a major player in cell and gene therapy?

24 November 2022

With European life sciences R&D investment at a 20-year low, biopharmaceutical associations and MEPs are calling on the EU to modernise its policies. DDW’s Diana Spencer asks what will be needed for Europe to compete in the growing global market for advanced therapies.  A new report by Charles River Associates for the European Federation of […]